Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Change in Cash (2022 - 2026)

Centessa Pharmaceuticals has reported Change in Cash over the past 4 years, most recently at $11.1 million for Q4 2025.

  • Quarterly Change in Cash rose 194.38% to $11.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$321.3 million through Dec 2025, down 225.89% year-over-year, with the annual reading at -$321.3 million for FY2025, 225.89% down from the prior year.
  • Change in Cash was $11.1 million for Q4 2025 at Centessa Pharmaceuticals, up from $6.6 million in the prior quarter.
  • Over five years, Change in Cash peaked at $267.7 million in Q3 2024 and troughed at -$278.1 million in Q1 2025.
  • The 4-year median for Change in Cash is -$41.4 million (2022), against an average of -$33.3 million.
  • Year-over-year, Change in Cash surged 918.55% in 2024 and then crashed 2733.93% in 2025.
  • A 4-year view of Change in Cash shows it stood at -$51.2 million in 2022, then rose by 15.1% to -$43.5 million in 2023, then soared by 72.84% to -$11.8 million in 2024, then soared by 194.38% to $11.1 million in 2025.
  • Per Business Quant, the three most recent readings for CNTA's Change in Cash are $11.1 million (Q4 2025), $6.6 million (Q3 2025), and -$60.9 million (Q2 2025).